SORL1 and Alzheimer disease: Research has shown that levels of SORL1-AS in plasma and brain are increased in AD patients compared to controls and are negatively correlated with the Mini-Mental State Examination (MMSE) scores of AD patients, indicating its potential as an important diagnostic biomarker for AD [175, 176].